BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28011392)

  • 1. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
    Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
    Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.
    Qosa H; Lichter J; Sarlo M; Markandaiah SS; McAvoy K; Richard JP; Jablonski MR; Maragakis NJ; Pasinelli P; Trotti D
    Glia; 2016 Aug; 64(8):1298-313. PubMed ID: 27158936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.
    Jablonski MR; Jacob DA; Campos C; Miller DS; Maragakis NJ; Pasinelli P; Trotti D
    Neurobiol Dis; 2012 Aug; 47(2):194-200. PubMed ID: 22521463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis.
    Mohamed LA; Markandaiah SS; Bonanno S; Pasinelli P; Trotti D
    Exp Neurol; 2019 Jun; 316():27-38. PubMed ID: 30974102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients.
    van Vliet EA; Iyer AM; Mesarosova L; Çolakoglu H; Anink JJ; van Tellingen O; Maragakis NJ; Shefner J; Bunt T; Aronica E
    J Neuropathol Exp Neurol; 2020 Mar; 79(3):266-276. PubMed ID: 31999342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.
    Wang X; Sykes DB; Miller DS
    Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 at the Blood-Brain Barrier.
    Cannon RE; Richards AC; Trexler AW; Juberg CT; Sinha B; Knudsen GA; Birnbaum LS
    Environ Health Perspect; 2020 Mar; 128(3):37002. PubMed ID: 32212926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis.
    Milane A; Fernandez C; Dupuis L; Buyse M; Loeffler JP; Farinotti R; Meininger V; Bensimon G
    Neurosci Lett; 2010 Mar; 472(3):166-70. PubMed ID: 20138122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.
    Wang X; Campos CR; Peart JC; Smith LK; Boni JL; Cannon RE; Miller DS
    J Neurosci; 2014 Jun; 34(25):8585-93. PubMed ID: 24948812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.
    Zhang W; Oh JH; Zhang W; Rathi S; Larson JD; Wechsler-Reya RJ; Sirianni RW; Elmquist WF
    J Pharmacol Exp Ther; 2023 Dec; 387(3):315-327. PubMed ID: 37827699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
    Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
    PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
    Harati R; Villégier AS; Banks WA; Mabondzo A
    J Neuroinflammation; 2012 Dec; 9():273. PubMed ID: 23253775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
    Li Y; Wu Q; Li C; Liu L; Du K; Shen J; Wu Y; Zhao X; Zhao M; Bao L; Gao J; Keep RF; Xiang J
    PLoS One; 2016; 11(6):e0157576. PubMed ID: 27300692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis.
    Jablonski M; Miller DS; Pasinelli P; Trotti D
    Brain Res; 2015 May; 1607():1-14. PubMed ID: 25175835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
    Hoque MT; Shah A; More V; Miller DS; Bendayan R
    J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies.
    Mohamed LA; Markandaiah S; Bonanno S; Pasinelli P; Trotti D
    AAPS J; 2017 Nov; 19(6):1600-1614. PubMed ID: 28779378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
    Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
    Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered blood-brain barrier and blood-spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety.
    Pan Y; Nicolazzo JA
    Br J Pharmacol; 2022 Jun; 179(11):2577-2588. PubMed ID: 35048358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology.
    Miller DS
    Adv Pharmacol; 2014; 71():1-24. PubMed ID: 25307212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting drug efflux transporters improves efficacy of ALS therapeutics.
    Jablonski MR; Markandaiah SS; Jacob D; Meng NJ; Li K; Gennaro V; Lepore AC; Trotti D; Pasinelli P
    Ann Clin Transl Neurol; 2014 Dec; 1(12):996-1005. PubMed ID: 25574474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.